1-20 of 21
Montserrat Hoyos
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk-Adapted Intensive Chemotherapy for Primary ACUTE Myeloid Leukemia during the Last 25 YEARS: Increase in Complete Remission RATE, Hematopoietic Cell Transplantation Access and Decrease in Relapse Incidence Have LED to Improved Survival

Ana Garrido, Montserrat Hoyos, Marina Diaz-Beyá, MD, Montserrat Arnan, MD, Susana Vives, MD, Marisa Calabuig, MD, Olga Salamero, MD, David Gallardo, MD, Maria Paz Queipo De Llano, MD, Lourdes Escoda, MD, Antonia Sampol, MD, Ferran Vall-Llovera, MD, Antonio Garcia-Guiñon, MD, Merchan Brayan, MD, Joan Bargay, MD, J Pio Torres, Xavier Ortin, M Luz Amigo, Jose Maria Moraleda, MD PhD, José F. Falantes, David Valcarcel, Mar Tormo, MD, Josep-Maria Ribera, Salut Brunet, MD, Anna Sureda Balari, MD PhD, Jordi Esteve, Jorge Sierra, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-140680
Published: 2020
Journal Articles

Validation of the European Leukemianet 2017 Prognostic Classification for Patients with De Novo Acute Myeloid Leukemia Treated with a Risk-Adapted Protocol (CETLAM 2012)

Alex Bataller, MD, Ana Garrido, MD, Francesca Guijarro, MD, Marina Diaz-Beyá, MD, Guadalupe Oñate, MD, Montserrat Hoyos, Montserrat Arnan, MD, Mar Tormo, MD, Susana Vives, MD, Maria Paz Queipo De Llano, MD, Olga Salamero, MD, Rosa Coll, MD, David Gallardo, MD, Ferran Vall-Llovera, MD, Lourdes Escoda, MD, Antonia Sampol, MD, Antonio Garcia-Guiñon, MD, Brayan Merchan, MD, Joan Bargay, MD, Monica Lopez-Guerra, PhD, Marta Pratcorona, MD, Lurdes Zamora, PhD, Salut Brunet, MD, Josep F Nomdedeu, MD, Jorge Sierra, MD, Jordi Esteve
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-140670
Published: 2020
Journal Articles

Prospective Population-Based Analysis of Characteristics and Therapy Options in AML: The Case of Catalonia (PERIS Project)

Montserrat Hoyos, Ana Garrido, Montserrat Arnan, MD, Marina Diaz-Beyá, MD, Olga Salamero, MD, Susana Vives, MD, Antonio Garcia-Guiñon, MD, David Gallardo, MD, Marta Cervera, MD, Ferran Vall-Llovera, MD, Cristina Motlló, Brayan Merchan, MD, Imma Roig Martinez, Xavier Ortin, Pável E Olivera, MD, Anna Sureda Balari, MD PhD, David Valcarcel, Josep-Maria Ribera, Jordi Esteve, Jorge Sierra, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-139160
Published: 2020
Journal Articles

Final Results of the AML12 Trial of the Spanish Cetlam Group in Adults with Acute Myeloid Leukemia (AML) up to the Age of 70 Years: Risk Adapted Post-Remission Allocation Based on Genetic Data and Minimal Residual Disease

Jorge Sierra, MD, Ana Garrido, Marina Diaz Beya, MD, Montserrat Hoyos, Marisa Calabuig, MD, Susana Vives, MD, Montserrat Arnan Sangerman, MD PhD, Maria Paz Queipo De Llano, MD, Olga Salamero, MD, Ferran Vall-Llovera, MD, Alex Bataller, Francisca Guijarro, MD, Lourdes Escoda, MD, Antonio Garcia-Guiñon, MD, Brayan Merchan, MD MSc, Xavier Ortin, Isabel Sanchez Ortega, MD PhD, Marta Pratcorona, MD PhD, Joan Bargay, MD PhD, Antonia Sampol, Josep Nomdedeu, MD PhD, David Gallardo, Josep-Maria Ribera, MD PhD, Mar Tormo, Jordi Esteve, Salut Brunet, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 289.
https://doi.org/10.1182/blood-2019-128682
Published: 2019
Journal Articles

Therapy for Acute Myeloid Leukemia (AML) Adjusted to Genetic Data and Minimal Residual Disease: Results of the AML12 Trial of the Spanish Cetlam Group in Adults up to the Age of 70 Years

Jorge Sierra, Ana Garrido, MD, Susana Vives, MD, Maria Paz Queipo De Llano, Ramon Guàrdia, MD, Marina Diaz-Beyá, Marisa Calabuig, MD, Marta Pratcorona, Montserrat Arnan Sangerman, Olga Salamero, Marta Cervera, MD, Antonia Sampol, MD, Antoni Garcia-Guiñon, Carme Pedro, Josep M Marti, Joan Bargay, MD PhD, Llorenç Font, Josep F Nomdedeu, Montserrat Hoyos, Lourdes Escoda, Montserrat Batlle, Bryan Merchan, Isabel Sanchez-Ortega, Physician, Mar Tormo, MD PhD, David Gallardo, Josep-Maria Ribera, MD, Jordi Esteve, MD, Salut Brunet, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 567.
https://doi.org/10.1182/blood.V130.Suppl_1.567.567
Published: 2017
Journal Articles

Favorable Outcome of Older Patients with AML and a Favorable Genotype NPM1mut FLT3-ITD Treated with Intensive Chemotherapy: A Subgroup Analysis of Cetlam Protocol 2003 & 2012

Marta Pratcorona, Jordi Lopez-Pardo, MD, Ana Garrido, MD, Salut Brunet, MD PhD, Josep-Maria Ribera, MD PhD, Mar Tormo, MD PhD, Lourdes Escoda, MD PhD, Olga Salamero, Montserrat Arnan, MD PhD, David Gallardo, MD, Joan Bargay, MD, Montserrat Hoyos, PhD, Marina Diaz-Beya, MD PhD, Ruth M Risueño, Josep F. Nomdedeu, MD PhD, Jorge Sierra, MD PhD, Jordi Esteve, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2511.
https://doi.org/10.1182/blood.V126.23.2511.2511
Published: 2015
Journal Articles

Prognostic Impact of MLL Partial Tandem Duplication in Acute Myeloid Leukemia of Intermediate Cytogenetic Risk: A Subgroup Analysis of Cetlam Protocol 2003 & 2012

Marta Pratcorona, Ana Garrido, MD, Salut Brunet, MD PhD, Jordi Esteve, MD PhD, María Camino Estivill, PhD, M. Paz Queipo De Llano, MD, Susana Vives, Montserrat Arnan, MD PhD, David Gallardo, MD, Mar Tormo, MD PhD, Antoni Garcia-Guiñon, MD, Antonia Sampol, MD PhD, Olga Salamero, Josep Ma Martí, MD, Joan Bargay, MD PhD, M Carmen Pedro, MD, Montserrat Hoyos, PhD, Marina Diaz-Beya, MD PhD, Lourdes Escoda, MD PhD, Ramon Guàrdia, MD PhD, Josep Ribera, MD PhD, Jorge Sierra, MD PhD, Josep F. Nomdedeu, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2514.
https://doi.org/10.1182/blood.V126.23.2514.2514
Published: 2015
Journal Articles

Allogeneic Hematopoietic Stem-Cell Transplantation (HSCT) in First Complete Remission Is Superior Compared to Chemotherapy/Autologous HSCT in Patients with Intermediate-Risk Cytogenetics Acute Myeloid Leukemia Lacking Mutations in NPM1 , FLT3 -ITD, and CEBPA : A Joint Study of AMLSG, Cetlam and Acute Leukemia Working Party of EBMT

Jordi Esteve, MD PhD, Myriam Labopin, MD, Marta Pratcorona, MD PhD, Felicitas Thol, MD, Salut Brunet, MD PhD, Michael Heuser, MD, Gudrun Göhring, PD, Arnold Ganser, MD PhD, Konstanze Döhner, MD, Peter Paschka, MD, Verena I. Gaidzik, MD, Arnaud Pigneux, MD PhD, Gerard Socie, MD PhD, Jan J. Cornelissen, MD PhD, Michel Attal, Jean-Henri Bouhris, MD, Johan Maertens, MD, Didier Blaise, MD PhD, Mar Tormo, MDPhD, Josep-Maria Ribera, MD PhD, Marina Díaz-Beyá, MD PhD, Montserrat Hoyos, PhD, Jordi Sierra, MD PhD, Mohamad Mohty, MD PhD, Arnon Nagler, MD, Hartmut Dohner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2014) 124 (21): 324.
https://doi.org/10.1182/blood.V124.21.324.324
Published: 2014
Journal Articles

The Impact Of European Leukemia Net (ELN) Genetic Classification On The Outcome Of Allogeneic Stem Cell Transplantation (ALLOHCT) For Acute Myeloid Leukemia (AML) In First Complete Remission

Jorge Sierra, PhD, MD, Ana Garrido, MD, Mar Tormo, MD, Ramon Guardia, MD, Josep F Nomdedeu, MD, Jordi Esteve, MD, PhD, Josep-Maria Ribera, MD, PhD, Rafael F. Duarte, MD, PhD, M. Paz Queipo De Llano, MD, Olga Salamero, MD, Carmen Pedro, MD, Joan Bargay, MD, Juan Besalduch, MD, PhD, Andreu Llorente, MD, Montserrat Hoyos, Montserrat Arnan, MD, Marta Pratcorona, MD, Susana Vives, MD, Marisa Calabuig, MD, David Gallardo, MD, PhD, Salut Brunet, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2107.
https://doi.org/10.1182/blood.V122.21.2107.2107
Published: 2013
Journal Articles

Bone Marrow WT1 Levels In Long-Term Survivors Of Core-Binding Factor AML and Acute Promyelocytic Leukemia

Josep F Nomdedeu, MD, Montserrat Hoyos, Maite Carricondo, Elena Bussaglia, PhD, Maria-Concepcion Garcia-Dabrio, MD, Isabel Badell, MD, Camino Estivill, Ana Garrido, MD, Clara Martinez, MD, Salut Brunet, Anna Aventin, MD, Jorge Sierra, MD
Journal: Blood
Blood (2013) 122 (21): 4946.
https://doi.org/10.1182/blood.V122.21.4946.4946
Published: 2013
Journal Articles

BAALC -Associated Mir-3151 Is An Independent Prognostic Factor In Younger Patients With Intermediate-Risk Cytogenetic Acute Myeloid Leukemia

Marina Díaz-Beyá, MD, Alfons Navarro, PhD, Marta Pratcorona, MD, Salut Brunet, MD, PhD, Josep F Nomdedeu, MD, Josep-Maria Ribera, MD, PhD, Mar Tormo, MD, Rafael F. Duarte, MD, PhD, Olga Salamero, MD, David Gallardo, MD, PhD, Lourdes Escoda, Meritxell Nomdedeu, MD, PhD, Ruth M Risueño, PhD, Montserrat Hoyos, Francisco Cervantes, MD, PhD, Jorge Sierra, MD, PhD, Mariano Monzó, MD, PhD, Jordi Esteve, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2577.
https://doi.org/10.1182/blood.V122.21.2577.2577
Published: 2013
Journal Articles

Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3 -ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy

Brief Report
Marta Pratcorona, Salut Brunet, Josep Nomdedéu, Josep Maria Ribera, Mar Tormo, Rafael Duarte, Lourdes Escoda, Ramon Guàrdia, M. Paz Queipo de Llano, Olga Salamero, Joan Bargay, Carmen Pedro, Josep Maria Martí, Montserrat Torrebadell, Marina Díaz-Beyá, Mireia Camós, Dolors Colomer, Montserrat Hoyos, Jorge Sierra, Jordi Esteve
Journal: Blood
Blood (2013) 121 (14): 2734–2738.
https://doi.org/10.1182/blood-2012-06-431122
Published: 2013
Includes: Supplemental data
Journal Articles

WT1 Levels At Diagnosis and POST-Induction Provide Prognostic Information in Adult De Novo AML. Results From the Spanish Cetlam Group.

Josep F Nomdedeu, MD, Montserrat Hoyos, Maite Carricondo, Elena Bussaglia, PhD, Camino Estivill, Jordi Esteve, MD, PhD, Mar Tormo, Rafael F Duarte, MD, PhD, Olga Salamero, MD, PAZ Queipo De Llano, MD, Joan Bargay, Inmaculada Heras, Josep M Marti-Tutusaus, Andreu Llorente, Josep-Maria Ribera, MD, PhD, David Gallardo, MD, PhD, Anna Aventin, MD, Salut Brunet, Jorge Sierra, MD
Journal: Blood
Blood (2012) 120 (21): 2524.
https://doi.org/10.1182/blood.V120.21.2524.2524
Published: 2012
Journal Articles

Prognostic Impact of the Levels of Expression of Cell Surface Proteins Commonly Expressed by Blasts and Hematopoietic Precursor Cells in De Novo AML Patients: A Report From the Spanish Cetlam Study Group

Maria Concepcion Garcia-Dabrio, Montserrat Hoyos, Ana Garrido, Salut Brunet, Rafael F Duarte, MD, PhD, Josep-Maria Ribera, MD, PhD, Jordi Esteve, MD, PhD, Andreu Llorente, Mar Tormo, Ramon Guardia, Natalia Lloveras, Antoni Garcia, Inmaculada Heras, Juan Besalduch, M. Paz Queipo De Llano, MD, Javier Bueno, Joan Bargay, Pio Torres, Josep M. Marti-Tutusaus, Llorenç Font, Anna Aventin, MD, Quentin Lecrevisse, Alberto Orfao, Jorge Sierra, MD, PhD, Josep F. Nomdedeu, MD
Journal: Blood
Blood (2012) 120 (21): 1452.
https://doi.org/10.1182/blood.V120.21.1452.1452
Published: 2012
Journal Articles

Improved Response to 5-Azacitidine in Patients with Primary Compared to Secondary AML, Particularly If NPM1 Mutations Are Present,

Ana Garrido, Miguel Ortin, Montserrat Hoyos, Rodrigo Martino, MD, PhD, Anna Aventin, MD, Josep Nomdedeu, MD, Salut Brunet, Jordi Sierra
Journal: Blood
Blood (2011) 118 (21): 3562.
https://doi.org/10.1182/blood.V118.21.3562.3562
Published: 2011
Journal Articles

5-Azacytidine Before or After Stem Cell Transplantation in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndromes (MDS)

Ana Garrido, Miguel Ortín, Rodrigo Martino, MD, PhD, Josep Nomdedeu, MD, Ana Aventin, Montserrat Hoyos, Salut Brunet, Jordi Sierra
Journal: Blood
Blood (2011) 118 (21): 4267.
https://doi.org/10.1182/blood.V118.21.4267.4267
Published: 2011
Journal Articles

Treatment for Primary Acute Myeloid Leukemia: Results of Two Consecutive Trials From the Spanish CETLAM Group Showing Improvement with the Use of G-CSF Priming and Precise Risk-Adapted Therapy.

Jorge Sierra, MD, Montserrat Hoyos, Josep F. Nomdedeu, MD, Jordi Esteve, MD, PhD, Rafael F. Duarte, MD, PhD, Josep-Maria Ribera, MD, PhD, Mar Tormo, MD, PhD, Ramon Guardia, Andreu Llorente, Javier Bueno, Juan Besalduch, M. Paz Queipo, Josep M. Marti-Tutusaus, Carmen Pedro, Pio Torres, Antoni Garcia, Inmaculada Heras, Joan Bargay, Llorenç Font, Jose Gonzalez, Antonia Sampol, MD, PhD, Olga Salamero, MD, Lourdes Escoda, David Gallardo, MD, PhD, Marisa Calabuig, Albert Oriol, Montserrat Arnan, Marta Pratcorona, Salut Brunet
Journal: Blood
Blood (2010) 116 (21): 1066.
https://doi.org/10.1182/blood.V116.21.1066.1066
Published: 2010
Journal Articles

Validation of the European Leukemia Net (ELN) Genetic Classification of Acute Myeloid Leukemia: Inclusion of Monosomal Karyotype Improves Prognostic Discrimination

Montserrat Hoyos, Salut Brunet, Josep F. Nomdedeu, MD, Jordi Esteve, MD, PhD, Rafael F. Duarte, MD, PhD, Josep-Maria Ribera, MD, PhD, Mar Tormo, MD, PhD, Andreu Llorente, Ramon Guardia, M. Paz Queipo, Javier Bueno, Juan Besalduch, Pio Torres, Inmaculada Heras, Carmen Pedro, Josep M. Martí-Tutusaus, Antoni Garcia, Joan Bargay, Llorenç Font, Antonia Sampol, MD, PhD, Olga Salamero, MD, David Gallardo, MD, PhD, Lourdes Escoda, Marisa Calabuig, Montserrat Arnan, Marta Pratcorona, Jorge Sierra, MD
Journal: Blood
Blood (2010) 116 (21): 1712.
https://doi.org/10.1182/blood.V116.21.1712.1712
Published: 2010
Journal Articles

Prognostic Value of Monosomal Karyotype in Patients with Primary Acute Myeloid Leukemia On Behalf of Spanish CETLAM Group.

Isabel Granada, Salut Brunet, Montserrat Hoyos, Dolors Costa, Anna Aventín, Isabel Marugán, Teresa Vallespí, Marta Barnues, JJ Duarte, Francesc Solé, Montserrat Teixidó, M. Mascaró, Andreu Llorente, Ramon Guardia, Mar Tormo, Rafael F. Duarte, Fuensanta Millá, Jordi Esteve, Josep-Maria Ribera, MD, PhD, Jordi Sierra
Journal: Blood
Blood (2009) 114 (22): 1003.
https://doi.org/10.1182/blood.V114.22.1003.1003
Published: 2009
Journal Articles

Impact of Cytogenetics and New Molecular Markers On the Achievement of Complete Remission in Patients with Primary Acute Myeloid Leukemia. On Behalf of CETLAM Cooperative Group. Spain.

Salut Brunet, Mar Tormo, Jordi Esteve, Josep M. Ribera, Montserrat Hoyos, Josep F. Nomdedeu, Rafael Duarte, Andreu Llorente, Ramon Guardia, M. Paz Queipo de Llano, Joan Besalduch, Inmaculada Heras, Joan Bargay, Carmen Pedro, Josep M. Marti, Javier Bueno, Pio Torres, Dolores Hernandez, Jose Gonzalez, Antoni Garcia, Llorenç Font, Montserrat Arnan, Albert Oriol, David Gallardo, Rosa Goterris, Emili Montserrat, Jorge Sierra
Journal: Blood
Blood (2009) 114 (22): 4711.
https://doi.org/10.1182/blood.V114.22.4711.4711
Published: 2009